These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22679555)

  • 1. Do cancer cells undergo phenotypic switching? The case for imperfect cancer stem cell markers.
    Zapperi S; La Porta CA
    Sci Rep; 2012; 2():441. PubMed ID: 22679555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Stem Cells.
    Woodward WA; Hill RP
    Recent Results Cancer Res; 2016; 198():25-44. PubMed ID: 27318680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Cancer Cell Lines Have Fixed or Fluctuating Stem Cell Phenotypes? - Studies with the NTera2 Cell Line.
    Sellers ZP; Schneider G; Bujko K; Suszynska M; Pedziwiatr D
    Stem Cell Rev Rep; 2017 Oct; 13(5):603-610. PubMed ID: 28624968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexity in cancer stem cells and tumor evolution: Toward precision medicine.
    La Porta CAM; Zapperi S
    Semin Cancer Biol; 2017 Jun; 44():3-9. PubMed ID: 28254567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cell targeted therapy: progress amid controversies.
    Wang T; Shigdar S; Gantier MP; Hou Y; Wang L; Li Y; Shamaileh HA; Yin W; Zhou SF; Zhao X; Duan W
    Oncotarget; 2015 Dec; 6(42):44191-206. PubMed ID: 26496035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Searching for prostate cancer stem cells: markers and methods.
    Sharpe B; Beresford M; Bowen R; Mitchard J; Chalmers AD
    Stem Cell Rev Rep; 2013 Oct; 9(5):721-30. PubMed ID: 23775699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells: distinct entities or dynamically regulated phenotypes?
    Li Y; Laterra J
    Cancer Res; 2012 Feb; 72(3):576-80. PubMed ID: 22298594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations.
    Grasso C; Anaka M; Hofmann O; Sompallae R; Broadley K; Hide W; Berridge MV; Cebon J; Behren A; McConnell MJ
    BMC Cancer; 2016 Sep; 16(1):726. PubMed ID: 27613604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells.
    Kim H; Lin Q; Glazer PM; Yun Z
    Breast Cancer Res; 2018 Mar; 20(1):16. PubMed ID: 29510720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bad seed: Cancer stem cells in tumor development and resistance.
    Koren E; Fuchs Y
    Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.
    Grosse-Gehling P; Fargeas CA; Dittfeld C; Garbe Y; Alison MR; Corbeil D; Kunz-Schughart LA
    J Pathol; 2013 Feb; 229(3):355-78. PubMed ID: 22899341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity.
    Jaggupilli A; Elkord E
    Clin Dev Immunol; 2012; 2012():708036. PubMed ID: 22693526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface Markers for the Identification of Cancer Stem Cells.
    Gopalan V; Islam F; Lam AK
    Methods Mol Biol; 2018; 1692():17-29. PubMed ID: 28986883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracing the cellular origin of cancer.
    Blanpain C
    Nat Cell Biol; 2013 Feb; 15(2):126-34. PubMed ID: 23334500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour heterogeneity and metastasis at single-cell resolution.
    Lawson DA; Kessenbrock K; Davis RT; Pervolarakis N; Werb Z
    Nat Cell Biol; 2018 Dec; 20(12):1349-1360. PubMed ID: 30482943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Implications of "Random Chance" in Cancer Genesis: Why Stochastic Can Be a Dirty Word.
    Meisenberg BR
    JAMA Oncol; 2015 Aug; 1(5):575-6. PubMed ID: 26181509
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model.
    Coulon A; Flahaut M; Mühlethaler-Mottet A; Meier R; Liberman J; Balmas-Bourloud K; Nardou K; Yan P; Tercier S; Joseph JM; Sommer L; Gross N
    Neoplasia; 2011 Oct; 13(10):991-1004. PubMed ID: 22028624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.